Characteristics of Academic Inventors on Government-Linked US Drug Patents

JAMA. 2024 Dec 17;332(23):2032-2033. doi: 10.1001/jama.2024.20361.

Authors

Matthew J Martin¹, Sarah M E Gabriele¹, Aaron S Kesselheim¹, S Sean Tu²

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
² West Virginia University College of Law, Morgantown.

PMID: 39570615
PMCID: PMC11583014 (available on 2025-05-21)
DOI: 10.1001/jama.2024.20361

No abstract available

Plain language summary

This study examines the characteristics of academic researchers who obtained US government–linked drug patents.